Results 101 to 110 of about 4,425,847 (185)

Anti-tumor activities of CIK cells derived from lymph nodes of lung cancer patients

Zhongguo aizheng zazhi, 2015
Background and purpose: Cytokine-induced killer (CIK) has both the advantages of T lymphocytes’ powerful anti-tumor activity and NK cells’ tumor killing capacity without MHC restriction.
滕家俊, 周　严, 刘显勋
doaj  

Feasibility and Safety of Adoptive Immunotherapy with CIK Cells after Cord Blood Transplantation

Biology of Blood and Marrow Transplantation, 2010
Five patients with aggressive acute leukemias who had relapsed after cord blood transplantation were treated with cord blood derived cytokine-induced killer (CIK) cells. These were obtained by ex vivo expansion, using as starting material the washouts of the cord blood units, left over at the end of the transplant.
Introna, M, PIEVANI, ALICE SILVIA, Borleri, G, Capelli, C, Algarotti, A, Micò, C, Grassi, A, Oldani, E, Golay, J, Rambaldi, A.   +9 more
openaire   +2 more sources

Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells

GMS German Medical Science, 2016
We examined the cytotoxic effects of chaetocin on clear cell renal cell carcinoma (ccRCC) cells and the possibility to combine the effects of chaetocin with the effects of cytokine-induced killer cells (CIK) assayed by MTT assay and FACS analysis ...
Rombo, Roman, Weiher, Hans, Schmidt-Wolf, Ingo G.H.   +2 more
doaj   +1 more source

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

Journal of Immunology Research, 2014
Tumors of the gastrointestinal system represent a significant share of solid tumors worldwide. Despite the advances in diagnosis and treatment, the prognosis of gastrointestinal tumors is still very poor and improved therapies are indispensable. Cytokine-
Clara E. Jäkel, Annabelle Vogt, Maria A. Gonzalez-Carmona, Ingo G. H. Schmidt-Wolf   +3 more
doaj   +1 more source

Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible. [PDF]

Front Immunol, 2023
Ma X, Peng L, Wang J, Gao L, Zhang W, Lu X, Liu J, Yang L.   +7 more
europepmc   +1 more source

Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway

Clinical & Translational Immunology
Objectives The rapid recognition of epigenetic manipulation's potential in restricting cancer cell capabilities spurred translational initiatives, including histone deacetylase inhibitors (HDACis).
Jingjing Pu, Amit Sharma, Ting Liu, Jian Hou, Ingo GH Schmidt‐Wolf   +4 more
doaj   +1 more source

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

, 2012
Cytokine-induced killer (CIK) cells may serve as an alternative approach to adoptive donor lymphocyte infusions (DLI) for patients with acute leukemia relapsing after haplo-identical hematopoietic stem cell transplantation (HSCT).
Martin Ruthardt, Willasch, Andre, Bader, Peter, Becker, Petra, Simone Fulda, Petra Becker, Klingebiel, Thomas, Bug, Gesine, Peter Bader, Koehl, Ulrike, Ruthardt, Martin, Eva Rettinger, Martina Anzaghe, Thomas Klingebiel, Naumann, Ivonne, Ivonne Naumann, KuçI, Selim, Fulda, Simone, Selim KuçI, Ulrike Koehl, Kreyenberg, Hermann, Anzaghe, Martina, Rettinger, Eva, Gesine Bug, Hermann Kreyenberg, Andre Willasch   +25 more
core   +1 more source

Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden. [PDF]

Blood, 2023
Biondi M, Tettamanti S, Galimberti S, Cerina B, Tomasoni C, Piazza R, Donsante S, Bido S, Perriello VM, Broccoli V, Doni A, Dazzi F, Mantovani A, Dotti G, Biondi A, Pievani A, Serafini M.   +16 more
europepmc   +1 more source

Clinical Trial Analysis of Different Stages of HBV Patients Treated with Human CIK Cells

, 2016
Cellular immunotherapy has become a potential therapeutic method for different diseases. Herein, we reported clinical trial results of Cytokine-induced killer (CIK) cells used for patients with hepatitis B, cirrhosis and liver cancers from 2000 to 2015 ...
Ruihua Song, Yao Yang, Zheng Wang, Lijun Ma, Ling He, Jingjing Zhang, Yun Cao, Jian Ni, Daxiang Cui, Ding Li, Fangfang Xia, Chenlu Li, Shangli Cheng, Yang Zhu   +13 more
core   +1 more source

Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells. [PDF]

Front Immunol, 2022
Zúñiga TM, Baker FL, Smith KA, Batatinha H, Lau B, Gustafson MP, Katsanis E, Simpson RJ.   +7 more
europepmc   +1 more source